MUTO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 5.870
EU - Europa 1.103
AS - Asia 630
AF - Africa 151
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 2
Totale 7.761
Nazione #
US - Stati Uniti d'America 5.840
SG - Singapore 339
FI - Finlandia 258
IE - Irlanda 258
IT - Italia 188
CN - Cina 180
NG - Nigeria 151
FR - Francia 98
DE - Germania 93
NL - Olanda 85
GB - Regno Unito 50
TR - Turchia 50
SE - Svezia 40
CA - Canada 30
IL - Israele 30
IN - India 16
BE - Belgio 13
ES - Italia 6
IR - Iran 6
EU - Europa 5
HK - Hong Kong 4
RU - Federazione Russa 4
PL - Polonia 3
UA - Ucraina 3
JP - Giappone 2
RO - Romania 2
AT - Austria 1
BR - Brasile 1
EC - Ecuador 1
KR - Corea 1
LU - Lussemburgo 1
PK - Pakistan 1
VN - Vietnam 1
Totale 7.761
Città #
Wilmington 1.267
Chandler 1.051
San Mateo 489
Ann Arbor 338
Helsinki 258
Dublin 257
Leawood 227
Singapore 224
Ashburn 210
Lawrence 210
Princeton 210
Shanghai 176
Boardman 158
Benin City 151
Fairfield 121
Woodbridge 116
Paris 96
New York 93
Amsterdam 75
Seattle 60
Kocaeli 41
London 40
Norwalk 38
Milan 31
San Diego 30
Toronto 28
Phoenix 21
Monmouth Junction 15
Pune 15
Los Angeles 14
Redmond 14
Brussels 13
Santa Clara 11
Falkenstein 10
Abbiategrasso 9
Fasano 8
Meppel 8
Redwood City 7
Rome 6
Des Moines 5
Istanbul 5
Torino 5
Frankfurt am Main 4
Hanover 4
Longobardi 4
Naples 4
Trezzo sull'Adda 4
Birmingham 3
Bologna 3
Catania 3
Cinisello Balsamo 3
Munich 3
Andezeno 2
Barakaldo 2
Berlin 2
Bucharest 2
Duncan 2
Hong Kong 2
Madrid 2
Moscow 2
Mountain View 2
Nettuno 2
Padova 2
Philadelphia 2
Ridgewood 2
Salerno 2
San Polo dei Cavalieri 2
Turin 2
York 2
Antalya 1
Augusta 1
Aversa 1
Caltanissetta 1
Cambridge 1
Cisterna Di Latina 1
Citta 1
Clearwater 1
Clifton 1
Cologno Monzese 1
Corpus Christi 1
Cutrofiano 1
Dolo 1
Dunboyne 1
Dunfermline 1
Elk Grove Village 1
Florence 1
Genoa 1
Girona 1
Glen Burnie 1
Goiânia 1
Guangzhou 1
Hangzhou 1
Hanoi 1
Hickory 1
Kashan 1
Klagenfurt 1
Las Vegas 1
Messina 1
Minerbio 1
Mumbai 1
Totale 6.261
Nome #
L'ADENOMA NEFROGENICO DELLA VESCICA ASSOCIATO A TUBERCOLOSI URINARIA 85
THUVEP: VAPOENUCLEAZIONE DELLA PROSTATA CON LASER TULLIO. LA NOSTRA ESPERIENZA 85
18 F-CHOLINE PET/CT GUIDED SUPEREXTENDED PLND FOR VERY HIGH RISK PCA. FEASIBILITY AND SURGICAL TECHNIQUE 74
An Unusual Cause of Hematuria: Primary Bladder Melanoma in an Older Man 60
ALCUNI ASPETTI ANATOMO-ISTOLOGICI DEGLI ADENOCARCINOMI RENALI 59
ABLAZIONE TRANSURETRALE DI PROSTATA CON AGHI (TUNA): RISULTATI PRELIMINARI 58
LE SUTURATRICI MECCANICHE NELLE DERIVAZIONI URINARIE E NELLE SOSTITUZIONI ORTOTOPICHE DI VESCICA 57
L'URETEROSCOPIA DIAGNOSTICA E OPERATIVA. ESPERIENZA DI 41 CASI 56
SEMINAL SPARING CYSTECTOMY AND ILEOCAPSULOPLASTY:LONG-TERM FOLLOWUP RESULTS 56
A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with fnal histopathology after radical prostatectomy 56
Benefits and shortcomings of superselective transarterial embolization of renal tumors before zero ischemia laparoscopic partial nephrectomy 55
LA NEFROCISTOCENTESI PREOPERATORIA QUALE TEST DI IPERTENSIONE NEFROGENA 55
A microRNA code for prostate cancer metastasis 54
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 54
FISTOLA ENTERO-VESCICALE DA LINFOMA ILEALE PRIMITIVO 53
LA CASTRAZIONE CHIRURGICA 53
Visually Directed Transrectal High Intensity Focused Ultrasound for the Treatment of Prostate Cancer: A Preliminary Report on the Italian Experience 53
Fusion biopsy improves prostate cancer detection in the first set biopsy: Development of a clinical nomogram 53
LA CHIRURGIA CONSERVATIVA DEI TUMORI RENALI 52
BENEFITS AND COMPLICATIONS OF LAPAROSCOPIC PELVIC LYMPHADENECTOMY FPR DETECTION OF STAGE D1 PROSTATE CANCER: A MULTICENTER EXPERIENCE 52
SEMINAL-SPARING CYSTECTOMY AND ILEOCAPSULOPLASTY 51
Reply by the Authors 51
Metabolic syndrome increases the risk of upgrading and upstaging in patients with prostate cancer on biopsy: a radical prostatectomy multicenter cohort study 50
UN CASO DI FEOCROMOCITOMA CON PRESENTAZIONE CLINICA ATIPICA 50
PERCORSO DIAGNOSTICO-TERAPEUTICO PER IL PAZIENTE CON CALCOLOSI URINARIA 50
Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative 50
ASPETTI CHIRURGICI 50
L'URETERO PIELOSCOPIA DIAGNOSTICA E TERAPEUTICA 50
RESEZIONE EN BLOC DELLE NEOFORMAZIONI VESCICALI MEDIANTE LASER: “UN TRATTAMENTO IN VIA DI AFFERMAZIONE” 50
SU DI UN CASO DI METASTASI URETRALE DA ADENOCARCINOMA DELLA PROSTATA 49
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscleinvasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial 49
ALTERAZIONI CITOGENETICHE NEL CARCINOMA RENALE 49
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial–mesenchymal transition 49
Recurrent Pseudodiverticula of Female Urethra: Five-year Experience 48
Quality of Life After Prostate Cancer Diagnosis: Data from the Pros-IT CNR. 48
Assessment of long term functional outcomes in more than 1000 patients treated with minimally ischemic partial nephrectomy 48
The Turin Pouch: A New Technique of Ileocecal Cutaneous Continent Urinary Diversion 48
Multiparametric magnetic resonance imaging of the prostate with computer-aided detection: experienced observer performance study. 47
Urinary Diversions after Cystectomy: The Association of Clinical Factors, Complications, and Functional Results of Four Different Diversions 47
L'EMASCULAZIONE ELA TERAPIA ANTIBLASTICA DISTRETTUALE NEL TRATTAMENTO DELLE NEOPLASIE DEL PENE 47
Intensity-Modulated TR-HIFU (IMTR-HIFU) with Sonablate 500® for the treatment of localized prostate cancer. The right path tow ard a really minimally -invasive option? 47
CISTECTOMIA SEMINAL-SPARING CON ILEOCAPSULOPLASTICA 47
PREDICTIVE MODEL OF DISEASE FREE SURVIVAL AFTER RADICAL CYSTECTOMY 46
Re: Suprapubic Prostatectomy With a Novel Catheter 46
LA CISTOPROSTATECTOMIA CON RISPARMIO DELLA CAPSULA, DELLE VESCICOLE SEMINALI ED ILEOCAPSULOPLASTICA: UN ULTERIORE CONTRIBUTO ALLA TERAPIA DELLA COARTAZIONE VESCICALE 46
MINIMAL POST-PROSTATECTOMY PATIENTS DISCONFORT: NEW SUPRAPUBIC THREE-WAY CATHETER 45
TRANSURETHRAL ELECTROVAPORIZATION OF THE PROSTATE VS TRANSURETHRAL RESECTION 45
Ultrasonography-guided transrectal perineal drainage of retroanastomotic collections in orthotopic neobladder 45
Predictive model of disease free survival after radical cystectomy 45
Complications Following Radical Cystectomy for Bladder Cancer in the Elderly 44
IMPIEGO DEL SET "ONE STICK INTRODUCER SYSTEM" NELLA PIELOSTOMIA QUALE PRIMO TEMPO DELLA PIELO-URETERO-LITOTRIZIA (PUL) 44
Pros-IT CNR: an Italian prostate cancer monitoring project. 44
Accuracy of magnetic resonance imaging to identify pseudocapsule invasion in renal tumors. 44
LITOTRISSIA PERCUTANEA AD ULTRASUONI E LITOTOMIA CHIRURGICA: TRE ANNI A CONFRONTO 43
Multifunctional CoreShell Nanoparticles: Discovery of Previously Invisible Biomarkers 43
L'UTILIZZAZIONE DELLA NEFROSCOPIA PERCUTANEA PER PATOLOGIE ENDORENALI NON LITIASICHE 43
L'INNERVAZIONE VESCICALE E LA NEUROFISIOLOGIA DELLA MINZIONE IN RELAZIONE AL TEST DEL BETANECOLO 42
CONSERVATIVE TREATMENT OF IATROGENIC URINARY FISTULAS: THE VALUE OF CYANOACRYLIC GLUE 42
BENEFITS AND COMPLICATIONS OF LAPAROSCOPIC PELVIC LYMPHADENECTOMY FOR DETECTION OF STAGE D1 PROSTATE-CANCER - A MULTICENTER EXPERIENCE 42
LAPAROSCOPIC REMOVAL OF SEMINAL VESICLE FOR CYSTIC DISEASE 42
The antiproliferative B cell translocation gene 2 ( BTG- 2) is under post-transcriptional control of miR-21 in prostate cancer: Implications for tumorigenesis 42
A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy 42
Seminal-sparing Cystectomy: Technical Evolution and Results Over a 20-Year Period REPLY 41
URETHRAL OR PELVIC RECCURENCE IN PATIENTS SUBMITTED TO RADICAL CYSTECTOMY AND VESICAL SUBSTITUTION 41
The new Epstein gleason score classification significantly reduces upgrading in prostate cancer patients 41
CYANOACRYLIC GLUE: A MINIMALLY INVASIVE NONSURGICAL FIRST LINE APPROACH FOR THE TREATMENT OF SOME URINARY FISTULAS 41
THE GHONEIM ANTIREFLUX URETEROILEAL IMPLANTATION TECHNIQUE ON GIA STAPLER DETUBULARIZED ILEAL NEOBLADDER 41
LA TECNICA ANTIREFLUSSO DI GONHEIM SU NEOVESCICA ORTOTOPICA DETUBULIZZATA CON SUTURATRICI MECCANICHE 41
CHIRURGIA CONSERVATIVA DEI TUMORI RENALI 41
TRATTAMENTO CON LASER THULIUM DELLE NEOPLASIE RENALI - 3CM. 41
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 41
L'URETEROSCOPIA OPERATIVA: ASPORTAZIONE ENDOSCOPICA DI POLIPO FIBROSO DELL'URETERE 40
Renal cancer: new models and approach for personalizing therapy 40
PROSTATECTOMIA RADICALE: L'EMOSTASI DEL PLESSO PROSTATICO CON ENDO GIA (4 ANNI DI ESPERIENZA) 40
POSSIBILITA' E LIMITI DELLA TERAPIA CONSERVATIVA DEL CARCINOMA RENALE 40
ADRIAMYCIN IN THE CHEMOTHERAPY OF SUPERFICIAL BLADDER CANCER 40
PROSTATECTOMIA RADICALE PER CARCINOMA PROSTATICO pT3 pN0: RISULTATI A 8 ANNI 40
LE SUTURATRICI MECCANICHE PER LA CONFEZIONI DELLE NEOVESCICHE DOPO CISTECTOMIA RADICALE 40
Microwaves laparoscopic-guided renal cancer ablation: Value on histopathology and haemostacy 40
Huge Anterior Sacral Meningocele Simulating Bladder Retention 40
Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients 40
Minimally Invasive Buccal Mucosa Dorsal Graft for Female Distal Urethroplasty 40
FISTOLA URETERO-GLUTEA CONGENITA 39
The Inhibition of the Highly Expressed Mir-221 and Mir- 222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice 39
Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases 39
LETTERS THO THE EDITOR 39
TERAPIA CHIRURGICA DEI TUMORI SUPERFICIALI DELLA VESCICA. CISTOPROSTATECTOMIA CON RISPARMIO DELLE VESCICOLE SEMINALI: INDICAZIONI E TECNICA 39
SU DI UN RARO CASO SI ADENOCARCINOMA ESTESO IN RENE A FERRO DI CAVALLO 39
LA CISTOPROSTATECTOMIA NERVE-SPARING CON RISPARMIO DELLE VESCICOLE SEMINALI PER TUMORI VESCICALI MULTIFOCALI E PLURECIDIVI DI BASSO GRADO E STADIO. UN ULTERIORE CONTRIBUTO PER LA CONSERVAZIONE DELL'EREZIONE 39
PROPOSTA DI NA NUOVA TECNICA DI RIMODELLAGGIO DEL MEGAURETERE CON URETEROCELE CON SUTURATRICI MECCANICHE GIA ED ENDO-GIA 39
PUO' LA PIELONEFRITE ATIPICA SIMULARE UN TUMORE DEL RENE? DESCRIZIONE DI TRE CASI 39
PREDICTIVE MODEL OF DISEASE FREE SURVIVAL AFTER RADICAL CYSTECTOMY 39
LA LITOTRISSIA RENALE PERCUTANEA CON ULTRASUONI. ESPERIENZA SU 160 CASI 39
Seminal-sparing Cystectomy: Technical Evolution and Results Over a 20-Year Period 38
TUNA. CLINICAL RELIABILITY OF A NEW PROCEDURE FOR PROSTATIC OBSTRUCTION TREATMENT 38
Novel upfront sample enrichment nanotechnology identifies prostate, breast, colon, ovarian, lung, pancreatic, and melanoma cancer specific biomarker candidates 38
LE COMPLICANZE LITIASICHE SONO UNA LIMITAZIONE ALL'USIO DELLE SUTURATRICI MECCANICHE IN UROOGIA 38
INDIANA POUCH MODIFICATA: NOTE DI TECNICA E RISULTATI PRELIMINARI 38
Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound 38
DIAGNOSTIC PERFORMANCE OF MULTIPARAMETRIC MRI IN PROSTATE CANCER: PER CORE ANALYSIS OF TWO PROSPECTIVE ULTRASOUND/MRI FUSION BIOPSY DATASETS 38
Totale 4.634
Categoria #
all - tutte 64.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 0 0 9
2020/20212.371 21 16 17 14 2 736 360 167 475 302 7 254
2021/2022892 62 15 32 245 11 13 47 156 81 19 171 40
2022/20232.900 472 93 264 310 244 250 0 258 512 261 197 39
2023/20241.503 104 134 335 92 61 187 88 94 44 24 113 227
2024/2025120 35 51 11 17 6 0 0 0 0 0 0 0
Totale 7.795